A

Aura Biosciences

76 employees

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
biotechnology
development
Health Care
drug development
nanotechnology
Pharmaceutical
research

Date founded

2009

Funding rounds raised

Total raised

$80M

from 24 investors over 24 rounds

A

Aura Biosciences raised undisclosed on November 3, 2021

Investors: Ysios Capital

A

Aura Biosciences raised $80M on March 22, 2021

Investors: COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U., Chiesi Ventures, Lundbeckfonden / Lundbeck Foundation, Arix Bioscience plc, Advent Life Sciences, Ysios Capital, Surveyor Capital and Medicxi

A

Aura Biosciences raised undisclosed on June 25, 2020

Investors: Myelin VC

A

Aura Biosciences raised $40M on April 2, 2019

Investors: Medicxi

A

Aura Biosciences raised $30M on December 21, 2017

Investors: Chiesi Ventures, COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U., Lundbeckfonden / Lundbeck Foundation, Arix Bioscience plc, Ysios Capital, Advent Life Sciences and LI-COR Biosciences

A

Aura Biosciences raised $21M on March 5, 2015

Investors: Lysosomal Therapeutics Inc., Chiesi Ventures, Ysios Capital, Advent Life Sciences, Pappas Ventures and LI-COR Biosciences

FAQ